FGFR1 and lung cancer: The binding strength of the developed peptibodies may seem much lower than that of the target-binding mAbs, but subsequent experiments testing internalization of peptibodyF4_1 and F4_3 into lung cancer cells with high and low levels of the FGFR1 expression demonstrated that such affinity is sufficient for selective peptibody delivery into cells.